Shares in Shire plc rose by almost 10%


in
Shares in Shire plc rose by almost 10%, as traders reported talk of bid interest from Pfizer. Shire declined to comment. Shire has seen as a bid target, because of its strong portfolio of recently-launched drugs. Pfizer has been trying to come up with a plan to offset competition to its $12 billion-a-year cholesterol fighter Lipitor. It has earlier stated that it planned to expand in emerging markets and to speed up the launch of new drugs.